Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Exchange of Travoprost Intraocular Implant

ClinicalTrials.gov ID: NCT04615403

Public ClinicalTrials.gov record NCT04615403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 16, 2026, 3:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study objective is to evaluate the safety of the operative and surgical exchange procedure of Travoprost Intraocular Implant in subjects with open-angle glaucoma or ocular hypertension.

Study identification

NCT ID
NCT04615403
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Glaukos Corporation
Industry
Enrollment
33 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2020
Primary completion
Feb 27, 2022
Completion
Feb 27, 2022
Last update posted
Sep 25, 2023

2020 – 2022

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Inland Eye Specialists Hemet California 92545
North Bath Eye Associates, Inc. Petaluma California 94954
Eye Center of northern Colorado, PC Fort Collins Colorado 80525
The Eye Associates of Manatee Manatee Florida 34209
Ocala Eye Ocala Florida 34471
Center for Sight Sarasota Florida 34239
Jones Eye Clinic Sioux City Iowa 51104
D'Ambrosio Eye Care Lancaster Massachusetts 01523
Northern New Jersey Eye Institute South Orange New Jersey 07079
Oklahoma Eye Surgeons Oklahoma City Oklahoma 73112
Vance Thompson Vision Sioux Falls South Dakota 57108
Texan Eye Austin Texas 78746
Lehmann Eye Center Nacogdoches Texas 75965

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04615403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2023 · Synced Sep 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04615403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →